Zanubrutinib
BGB-3111-218
Phase 2 small_molecule completed
Quick answer
Zanubrutinib for Relapsed Diffuse Large B-cell Lymphoma is a Phase 2 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Relapsed Diffuse Large B-cell Lymphoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed